Cevec Pharmaceuticals Gmb H
Biotechnology, Gottfriedhagenstr 6062, Köln, Iowa, 51105, United States, 11-50 Employees
Who is CEVEC PHARMACEUTICALS GMBH
CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio compris...
Read More
-
Headquarters: Gottfriedhagenstr 6062, Köln, Iowa, 51105, United States
-
Date Founded: 2003
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from CEVEC PHARMACEUTICALS GMBH
CEVEC Pharmaceuticals GmbH Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CEVEC Pharmaceuticals GmbH
Answer: CEVEC Pharmaceuticals GmbH's headquarters are located at Gottfriedhagenstr 6062, Köln, Iowa, 51105, United States
Answer: CEVEC Pharmaceuticals GmbH's official website is https://cevec.com
Answer: CEVEC Pharmaceuticals GmbH's revenue is $1 Million to $5 Million
Answer: CEVEC Pharmaceuticals GmbH's SIC: 2834
Answer: CEVEC Pharmaceuticals GmbH's NAICS: 325412
Answer: CEVEC Pharmaceuticals GmbH has 11-50 employees
Answer: CEVEC Pharmaceuticals GmbH is in Biotechnology
Answer: CEVEC Pharmaceuticals GmbH contact info: Phone number: Website: https://cevec.com
Answer: CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises platform technologies for gene therapy viral vectors, vaccines and complex recombinant proteins. With the ELEVECTA® Technology, CEVEC offers a unique solution for large-scale production of AAV vectors using helper virus-free producer cell lines with all necessary components stably integrated into the cell. The technology is based on suspension cells and does not require any expensive transfection reagents nor cGMP plasmids. CEVEC’s CAP® Ad Technology is the ideal production platform for RCA-free adenoviral vectors. Based on human suspension cells, it allows for a robust manufacturing process, easy scale-up from research grade to industrial volumes and thus opens the way for various applications, from gene therapy to vaccine production. With the CAP-Go® Technology CEVEC provides a solution to the increasing need for recombinant production of complex and highly glycosylated protein molecules, including laminins, coagulation factors and plasma proteins.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month